Boston Sci opens multipurpose hub in India

Boston Scientific headquarters in Marlborough, MA--Courtesy of Boston Scientific

Boston Scientific ($BSX) launched an R&D, training and commercial hub in India, planting a foothold to sell minimally invasive technologies in the country as well as in greater Asia.

The facility joins Boston Sci’s other Institute for Advancing Science locations, which include sites in Japan, France and South Africa. The 100,000-square-foot space will house a physician-training facility for hands-on experience as well as an R&D center, which will develop products to address unmet medical needs in emerging markets, Press Trust of India reported.

“The launch of this facility underscores our commitment to India, and we are confident that our R&D activities will address many of the current health challenges of the country and the world,” said Prabal Chakraborty, vice president and managing director for Boston Scientific in India, as quoted by PTI.

Event

Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

India represents an opportunity for growth: increasing economic development and healthcare access drives up demand for medical devices. And by establishing a presence there, Boston Scientific will tap a new and growing market for its devices, including those for cardiovascular conditions and urologic and pelvic health.

In fiscal 2015, U.S. sales made up just over half of the devicemaker’s revenues. Boston Scientific made a number of moves ex-U.S., including the launch of metal stents in Asia and the investment in Peripheral Interventions in emerging markets. It also teamed up in April with Chinese surgical device maker Frankenman Medical Equipment to develop endoscopes for the Chinese market. Frankenman will also help commercialize some Boston Sci products in China.

- read the PTI story

Related Articles:
Boston Scientific takes its TAVR patent battle with Edwards stateside
Boston Scientific, Accenture partner for chronic cardio population health analytics
Boston Scientific targeted for 'international conspiracy' in latest vaginal mesh suit
Nevro scores a victory in spinal cord stimulation patent battle with Boston Scientific

Read more on

Suggested Articles

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.

Since launching Grail into the world in 2016, Illumina has watched the cancer blood test developer grow into a multibillion-dollar startup enterprise.